Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Really like HRVSF as my new investment and going to forego buying CCHWF for now. Have 4500 shares and believe my goal is 10k this week. The cool thing is even though I have made fantastic money the majority is in 401k. The more I see the more I like it. IMO, almost all of the metrics you have pointed out have been met here. Cash flow low positive and net income coming with huge growth. Perfect formula.
Just grabbed a few more at %4.31
Outstanding Shares
313,886,500
12/31/2020
Not the worst. Right in the middle between good and too many.
Third Quarter 2020 and YTD Financial Highlights:
Core cannabis revenues of $13.5 million "too low" in Q3 represent a 220% increase compared with $4.2 million in Q3 2019. For the nine months ended September 30, 2020, core cannabis revenues totaled $30.5 million, a 168% increase compared with $11.4 million for the first nine months of 2019;
Gross profit from the core cannabis business increased 221% to $8.7 million for Q3 compared with $2.7 million for the same period in 2019.
For the nine months ended September 30, 2020, gross profit from the core cannabis business totaled $19.7 million, a 159% increase from $7.6 million for the first nine months of 2019;
EBITDA for Q3 was $4.4 million compared to an EBITDA loss of $733,000 for the same period in 2019. GOOD!!
For the nine months ended September 30, 2020, EBITDA totaled $8.6 million compared to an EBITDA loss of $1.3 million for the first nine months of 2019; GOOD!
The foregoing 2019 revenues, gross profit and EBITDA information have been adjusted, for comparative purposes, to remove the impact from the one-time sales of hemp seeds during the same periods in 2019; and
The Company continues to take steps to improve financial flexibility and improve liquidity through debt restructuring activities.
How about Marimed?
Pretty much my thoughts. Also thinking about a position in Columbia Care. Like Harvest Health I believe the risk/reward in 6 month is zero risk. Just added another 1k of Harvest at $3.37
My criteria;
#1. I like to see at least 100M in annual sales.
#2. I like to see an outstanding share number of less than 300M.
#3. The stock must have momentum. Especially right now.
#4. The company should be on the way to EBITDA break-even, if not there yet.
#5. Maybe a turnaround story, or legit, right out of the box.
#6. Typically will be focused on the U.S., not Canada.
#7. For now, will be marijuana only. No hemp.
1) High Tide HOLD
2) AYR Resources SOLD
3) Green Thumb SOLD
4) Schwazze NO POSITION
4) HEXO BOUGHT
5) Columbia Care BOUGHT
6) TPCO Holding Inc ADDED
7) Jushi SOLD
8) Harvest Health BOUGHT BACK
9) CRESCO BOUGHT
10)4Front SOLD
11) Cannabix SOLD
12) TILT NO POSITION
13) Trulieve NO POSITION
14) Curaleaf NO POSITION
15) TILRAY NO POSITION
16) MENMEN NO POSITION
I agree. All the DD I have done says this is going to be a multi-bagger. IMO, all the MSO's are currently topped out for awhile until. At lest that is how I am playing it. My SHWZ has been on a tare.
Their future is brighter than ZZ Top.
Got 3k HRVSF today at $3.39. Probably gong to build a position and keep this long.
Cannabis price targets lifted by Echelon Capital off new regulatory outlook
Jan. 07, 2021
By: Clark Schultz, SA News Editor
Echelon Capital Markets resets price targets across the cannabis sector after factoring in the results of the Georgia Senate election and increased prospect for federal cannabis reform.
Analyst Andrew Semple calls it likely that progress will be made on the MORE Act towards the latter half of 2021 or possibly later if COVID-19 requires additional attention from lawmakers. That leads the firm to take the first step in normalizing valuations across the sector.
"Across our US cannabis coverage models, we previously used a discount rate of 15%, reflecting the high cost of debt and equity capital for these businesses largely attributable to the current status of federal cannabis regulations. We firmly believe the US cannabis industry will eventually move towards a normalized WACC of 4–6% (in the context of current market conditions) seen in more traditional CPG companies if/when full federal legalization occurs.
This has significant implications for long-term valuations across the sector."
Ayr Strategies (OTCQX:AYRWF) - Buy rating, price target boost to C$58 from C$53.
Columbia Care (OTCQX:CCHWF) - Speculative Buy rating, price target to C$13.00 from C$11.50.
Cresco Labs (OTCQX:CRLBF) - Buy rating, price target boost to C$16.00 from C$14.50.
Green Thumb Industries (OTCQX:GTBIF) - Buy rating, price target boost to C$38.00 from C$34.00
TerrAscend Corp. (OTCQX:TRSSF) - Speculative Buy rating, C$16.00 from C$14.50
Trulieve Cannabis (OTCQX:TCNNF) - Buy rating, price target boost to C$52.00 to C$43.00.
The cannabis sector saw big gains yesterday when the Georgia Senate election went to the Democrat candidates.
I have been in and out of Harvest Health. One of THE most undervalued MJ stocks. Even after the recent, large gains. Buying in the 3's is like shootin' fish in a barrel. I sold 4Front this morning and bought Harvest.
I know you love momo stocks. Thinking about getting into Harvest Health tomorrow. They certainly have a lot of things currently going for them. Plus they are getting a lot of ink lately.
TPCO Holding Corp. (GRAMF)
JohnCM Member Level
Wednesday, 01/13/21 10:18:21 AM
Re: Carm060606 post# 198
Post #198 of 288
$20 in 90 days.
Figured I would follow your board John, as you are in many of the same stocks as me and have good input, keep up the good work!
Coming out at $10.00
Keep an eye on another SPAC
GRAMF
I’ll keep a close eye on it!
Any volunteers??
Check www.otcmarkets.com daily for new ticker for the SPAC
Choice Consolidation Corp
Before and after META made quite a difference.
Oh well. Working out.
Share count looks bloated however,
Lots of warrants but also lots of time. Share count looks bloated however, they are growing nicely. Bought 32k today. GLTY
the MORE Act was already passed by Congress...awaiting for Senate approval...no need to introduce a new bill...uggghh...since Shurman is majleader now, this should pass Senate and issued to pres Biden for signature...
DarthYoda Member Level Thursday, 01/21/21 01:11:53 PM
Re: JohnCM post# 1656
Post #1658 of 1658
"Congressman Files First Federal Marijuana Reform Bill Of 2021":
January 21, 2021
Quote:
The first marijuana reform bill of the new Congress was introduced this week. It’s not the comprehensive legalization legislation that advocates are waiting for, but it would reschedule cannabis under federal law.
Rep. Greg Steube (R-FL) filed the proposal, which is identical to a measure he sponsored last session. It would simply move marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA).
https://www.marijuanamoment.net/congressman-files-first-federal-marijuana-reform-bill-of-2021/
On your watch list? You can watch it climb to $0.75 and then fall to $0.40.
Hey John
Congrats on the move! I do have HITIF on the watch list but in all honesty have done zero DD on this one yet, with no news, would you mind enlightening me on why you think this had the 42% move today, will look into more tomorrow. Chart looks good, love the moving average, RSI, strong volume, but doesn't appear that was the catalyst for this move.
Appreciate your thoughts as always!
FOF
High Tide Inc. (HITIF)
NOBODY KNOWS ABOUT THIS STOCK!!.
A huge day and only 2 messages on the discussion board.
Everyone is oblivious to this stock.
Which is good!!!!!!!!!!!!!!!!!!!
NOW I WANT TO WARN YOU!!
When all of the fanboys spot High Tide and drive it up. When the volume increases and the chart becomes parabolic.
When the RSI(14) hits 100. (It may have today, I'll have to check.) When these things happen. Keep an eagle eye on the chart and the price.
You want to JUMP OFF or lighten your load at the top!! Because the steep ramp, the parabolic move will not continue. The price will fall off a cliff, find a bottom and slowly resume its move, BUT at a MUCH slower pace.
My initial guess is the "ramp" will last 3 to 4 days.
I am just going to throw out some numbers without spending time, as yet, on this. Let's look at the buyout Liberty Health.
$0.40 to a buck. Now, I know this was driven by a buyout by AYR, but what if High Tide makes the same move, but drops because the is not supported by the buyout price floor?
Let's say High Tide at $0.30 makes the same 150 percent move. A 1 1/2 bagger is $0.75. Would you be happy selling at $0.75 or would you be a pig and get slaughtered? Bird in the hand? Or two in the bush?
My basis is $0.17. Would I be happy selling at $0.75? A 440 percent return? Yes. So, with 100,000 shares you place 10 limit orders.
SELL
10,000 $0.50
10,000 $0.55
10,000 $0.55
10,000 $0.65
10,000 $0.65
10,000 $0.70
10,000 $0.70
10,000 $0.75
10,000 $0.75
10,000 $0.75
that's a good one...MJ should do really well from now on...
There are mini-bubbles everywhere.
Yahoo Finance
Jan 15, 2023
By Myles Udland
The most unique feature of the modern market is how fast everything happens.
As we wrote back in November, the 2020 stock market essentially plotted the entire seven-year journey investors endured around the financial crisis in just seven months.
And as markets have moved to more quickly and efficiently discount all future outcomes, a series of mini-bubbles have become a defining feature of market today. And it appears SPACs (Special Purpose Acquisition Company) are taking their seat at the table.
George Livadas, portfolio manager at Upslope Capital Management, wrote cautiously about the SPAC space in his fourth-quarter investor letter published Wednesday.
“In recent years we’ve seen a number of mini-bubbles come and go rapidly (pot stocks, short vol, blockchain, etc),” Livadas writes.
“We’ve also seen what looks like a general speeding up of broader market regimes (flash bear markets of late 2018 and early 2020). For the SPAC bubble to be exempt from this phenomenon, one must assume that SPACs really are a better, lasting mousetrap vs. traditional IPOs. This seems highly unlikely.”
Livadas also cites impending lock-up expirations and the first full run of detailed quarterly results from many companies taken public by SPAC sponsors as risks for the space. Livadas disclosed that as of the end of the fourth quarter, Upslope was short 11 SPACs and two electric vehicle stocks, all as-yet unnamed.
But even the discussion of SPACs as a sector or asset class unto itself proves the enthusiasm has gone too far.
SPACs are, after all, just a financing scheme, an alternate route for companies to go public that requires fewer disclosures than a traditional IPO or direct listing process. In exchange for this easier process, the company being taken public offers a bigger part of itself for sale to the SPAC sponsor.
Traditionally, this higher level of dilution made SPACs attractive for turnaround stories. Existing shareholders in a business that is struggling are typically more willing to give up an ownership stake in exchange for fresh capital, or a new management team running the company.
Though as Goldman Sachs strategists noted back in December, the sectors now being targeted by SPAC sponsors are no longer beaten down turnaround stories but high growth areas like pharma, tech, and electric vehicles. The SPAC has shifted from being a last resort to a first choice for many companies.
Of course, many companies that choose the SPAC route to go public will indeed turn out to be great long-term businesses. A bubble doesn’t disqualify all those businesses or assets that get caught up in a market’s updraft. Just look at what’s happened to bitcoin (BTC-USD), ether (ETH-USD), and other major cryptocurrencies in the last year — after a crash in 2018, they’re now trading at record highs.
But in this modern market environment when fads can come and go so quickly and with so much force, Livadas sees now as the time to take a perhaps unpopular stand against the SPAC craze.
“A question I often get: why not just sit on the sidelines and wait for the SPAC craze to ‘break’ before putting on the shorts?” Livadas writes.
“My view is that this would likely lead to missing the downturn altogether, given the emotional challenge of quickly adding positions after what will likely be sudden, sharp declines. Instead, my approach here and with other high-beta shorts has historically been to ‘hang around the hoop’ (i.e. size small enough to survive and be ready to add when the inevitable break occurs).
“Nonetheless, I am keeping an open mind on all fronts — both with regards to each of the individual SPAC shorts and with the basket as a whole.”
#7. For now, will be marijuana only. No hemp.
what about CBDL??? They just opened another retail store...and they take credit cards...which means very little dilution possible...I hope soon the Senate will pass the MORE Act...then all these MJ stocks won't have to dilute, they would enjoy banking...
My criteria;
#1. I like to see at least 100M in annual sales.
#2. I like to see an outstanding share number of less than 300M.
#3. The stock must have momentum. Especially right now.
#4. The company should be on the way to EBITDA break-even, if not there yet.
#5. Maybe a turnaround story, or legit, right out of the box.
#6. Typically will be focused on the U.S., not Canada.
#7. For now, will be marijuana only. No hemp.
1) Subversive Capital ADDED
2) AYR Resources SOLD
3) Green Thumb
4) CRESCO BOUGHT
4) HEXO
5) Columbia Care
6) High Tide
7) Jushi SOLD
8) Harvest Health SOLD
9) Cannabix SOLD
10) 4Front
11) Schwazze NO POSITION
12) TILT NO POSITION
13) Trulieve NO POSITION
14) Curaleaf NO POSITION
15) TILRAY NO POSITION
16) MENMEN NO POSITION
You were the one who directed me that way from a prior post on this thread. Thanks it does look in breakout mode. Everything is on fire.
Took a 20k gamble on TLLTF at .47 today. It has very good volume and appears like it is going to break into yearly highs. Looking more and more like a momo stock. Like CNTMF which I bought back today also huge volume.
what's wrong with FUNN???
Dear lord not Amfil.
well, FUNN is getting into the Dispensary business, going through the cert process right now... https://www.otcmarkets.com/stock/funn/news/30-Day-Assessment-Report-from-Amfil-Technologies-Inc-CEO-Rogen-K-Chhabra?id=284576
Not touching oil, gas, gold or silver.
Way too involved with something I know very well ... Cannabis.
I've been waiting to get back into AMAZ again, but still stuck in WDLF...looks like AMAZ is following the price of oil...
Back in
CRESCO
Sold
Cannabix
Harvest Health
Added
Subversive
Thank you very much!!
Appreciate this John. As far as 1-7 I totally agree with everything you have pointed out as your criteria is very similar to mine. I am now down to 2 stocks and one is LHSIF. I bought that without the stock having momentum based on my feeling at the time it was severely undervalued and would become a buyout candidate as all dispensaries were total under performing yet they had a excellent footprint. I had 175k with pps at tad under .38 Really locked out there.
Your number 11 pick is SHWZ which IMO based on your criteria has met all of the criteria. However it kind of recently lost momentum as a large seller has recently appeared. However to get the 100MIL revenues it is very important that they do close on the remaining dispensaries this Q. I like the management and even though many deals that the prior management did not close they are not going to do anything that is going to harm shareholders. I was told the CEO put in over $20 Mil of his own money. Currently adding and feel very confident with this pick. No pumping here but not only is the CEO top notch but also the grower himself. I have heard he averages over 3 lbs. per plant and has a large holding of the stock. I had many flips lately on tier 2 stocks and now being very choosy going forward. GLTY and thanks for sharing your criteria as I believe it is excellent.
TOP 10 CANNABIS STOCKS
JANUARY 13, 2021
I typically list stocks that I own, and because of this, Trulieve, for example, is not here. There are a ton of companies that I like, who have participated and this last MJ bonanza. Curaleaf, Cresco, Canopy, Tilray, etc. I have chosen to have larger positions in a few, as opposed to spreading myself out.
Special note, all of the EFT funds are doing well, for the most part. A good way to go if you are having trouble selecting from all of the high flyers.
My criteria;
#1. I like to see at least 100M in annual sales.
#2. I like to see an outstanding share number of less than 300M.
#3. The stock must have momentum. Especially right now.
#4. The company should be on the way to EBITDA break-even, if not there yet.
#5. Maybe a turnaround story, or legit, right out of the box.
#6. Typically will be focused on the U.S., not Canada.
#7. For now, will be marijuana only. No hemp.
1) Subversive Capitol
2) AYR Resources SOLD
3) Green Thumb
4) Columbia Care
5) HEXO
6) High Tide
7) Jushi SOLD
8) Harvest Health
9) Cannabix BOUGHT
10) 4Front
11) Schwazze NO POSITION
JohnCM Investment Corner
My criteria;
#1. I like to see at least 100M in annual sales.
#2. I like to see an outstanding share number of less than 300M.
#3. The stock must have momentum. Especially right now.
#4. The company should be on the way to EBITDA break-even, if not there yet.
#5. Maybe a turnaround story, or legit, right out of the box.
#6. Typically will be focused on the U.S., not Canada.
#7. For now, will be marijuana only. No hemp.
#8. Price point (thus no Trulieve).
JAN 4TH, 2021
1) AYR Resources
2) Green Thumb
3) Subversive Capitol
4) Columbia Care
5) High Tide
6) Jushi
7) Harvest Health
8) HEXO
9) 4Front
10) Schwazze**
11) TILT**
FINISHED WEEK GREEN
NOT IN PORTFOLIO BUT INTERESTED**
JohnCM Investment Corner
Its number 3 on mine, if you don't mind me asking what are the ten above and why? (Sorry, know that's probably a long answer, lol)
TILT? On my radar screen. Held it recently. Maybe number 11 on my list.
Already in Madmen, they own Ascend LLC in IL who is a major supplier to Verilife, who have about 8 IL dispensaries, from what my wife has told me, their product is one of the best, lol.
Another Cannabis stock that seems to have some run in it is $TLLTF, just uplisted from OTCQX to OTCQB last week, EPS on this (not saying that is the only consideration) shows it should be trading up over $1, currently at around 0.38.
Best
Breakout alert.
You could park cash in Medmen at $0.15
... or you could put your cash to work in momentum, and set a break-out price alert for Medmen at $0.19
For me it is because things are constantly changing. For example I could have a buy order in for $1 a share while price is currently $1.35 Now some bad news comes out and the order triggers at $1 but it drops to .85 Hopefully that is what you were talking about.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |